Patents by Inventor Edward J Warawa

Edward J Warawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6417183
    Abstract: This invention provides substituted 1,2,3,4-tetrahydronaphthalene [3H]-emopamil binding site inhibitors useful in the treatment of neurological disorders. Such inhibitors are compounds of formula (I) wherein R, R1, m, R2 and n are as defined in the specification.
    Type: Grant
    Filed: June 15, 2000
    Date of Patent: July 9, 2002
    Assignee: Astrazenela UK Limited
    Inventors: Richard A Keith, Edward J Warawa, Thomas R Simpson
  • Patent number: 6407093
    Abstract: Emopamil inhibitors according to formula (I): wherein R, R1, m, R2 and n are as defined in the specification, useful in the treatment of neurological disorders, are disclosed. Also disclosed are pharmaceutical compositions containing the compounds, methods for using the compounds and methods for making the compounds.
    Type: Grant
    Filed: June 6, 2000
    Date of Patent: June 18, 2002
    Assignee: Astrazeneca UK Limited
    Inventor: Edward J Warawa
  • Patent number: 4975435
    Abstract: The present invention comprises certain quinoline lactams of formula I; pharmaceutically acceptable salts of the compounds of formula I; pharmaceutical compositions containing a compound of formula I, or a pharmaceutically acceptable salt thereof, for use in the treatment of anxiety; and processes for the manufacture of the compounds of formula I, as well as intermediates for use in such manufacture.
    Type: Grant
    Filed: April 29, 1987
    Date of Patent: December 4, 1990
    Assignee: ICI Americas Inc.
    Inventors: James B. Campbell, Edward J. Warawa
  • Patent number: 4904651
    Abstract: The present invention comprises certain amide derivatives of 4,8-disubstituted quinoline-3-carboxylic acids of formula I; pharmaceutically acceptable salts of the compounds of formula I; pharmaceutical compositions containing a compound of formula I, or a pharmaceutically acceptable salt thereof, for use in the treatment of anxiety; and processes for the manufacture of the compounds of formula I, as well as intermediates for use in such manufacture.
    Type: Grant
    Filed: August 3, 1988
    Date of Patent: February 27, 1990
    Assignee: ICI Americas Inc.
    Inventor: Edward J. Warawa
  • Patent number: 4879288
    Abstract: 11-[4-[2-(2-Hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo[b,f][1,4 ]thiazepine is disclosed as a neuroleptic with a much reduced incidence of side effects such as acute dystonia and dyskinesia and tardive diskinesia.
    Type: Grant
    Filed: March 20, 1987
    Date of Patent: November 7, 1989
    Assignee: ICI Americas Inc.
    Inventors: Edward J. Warawa, Bernard M. Migler